|
KMID : 0624620170500120601
|
|
BMB Reports
2017 Volume.50 No. 12 p.601 ~ p.609
|
|
|
Upstream signalling of mTORC1 and its hyperactivation in type 2 diabetes (T2D)
|
|
Ali Muhammad
Bukhari Shazia Anwer
Ali Muhammad
Lee Han-Woong
|
|
|
Abstract
|
|
|
|
Mammalian target of rapamycin complex 1 (mTORC1) plays a major role in cell growth, proliferation, polarity, differentiation, development, and controls transitioning between anabolic and catabolic states of the cell. It collects almost all extracellular and intracellular signals from growth factors, nutrients, and maintains cellular homeostasis, and is involved in several pathological conditions including, neurodegeneration, Type 2 diabetes (T2D), obesity, and cancer. In this review, we summarize current knowledge of upstream signaling of mTORC1 to explain etiology of T2D and hypertriglyceridemia, in which state, the role of telomere attrition is explained. We discuss if chronic inhibition of mTORC1 can reverse adverse effects resulting from hyperactivation. In conclusion, we suggest the regulatory roles of telomerase (TERT) and hexokinase II (HKII) on mTORC1 as possible remedies to treat hyperactivation. The former inhibits mTORC1 under nutrient-rich while the latter under starved condition. We provide an idea of TOS (TOR signaling) motifs that can be used for regulation of mTORC1.
|
|
|
KEYWORD
|
|
|
Diabetes, Hypertriglyceridemia, Insulin resistance, mTORC1 restriction
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|